Authors
Latest:
The Sleepy-Girl Mocktail Trend for Sleep Aid: A Pharmacist’s PerspectiveWith the current social media trend of the “Sleepy-Girl Mocktail” claiming to provide quality sleep, is this trend fact or faux as a quality sleep aid?
Latest:
Pharma Moves Toward Value-Based ContractingPart 1 of this 4-part series provides a general overview of the trends that are moving payers and pharmaceutical companies in this direction.
Latest:
The Fludarabine Shortage and Its Ripple Effects: Navigating the CrisisThe significant surge in oncology drug shortages in 2023 particularly affected essential chemotherapeutic drugs.
Latest:
Navigating Prescription Stimulant Use: Safety, Legal, and Supply Challenges in Pharmacy PracticeThe rising use of prescription stimulants in the US presents significant safety risks, legal challenges, and supply chain shortages, emphasizing the need for pharmacist involvement in promoting responsible prescribing.
Latest:
5 Quick Tips to Create a Transformative Advanced Pharmacy Practice Experiences RotationWhat many preceptors may not realize is that in addition to learning about practice settings, all graduates of pharmacy schools in the United States must also be able to demonstrate leadership, innovation, and entrepreneurship.
Latest:
Updated Clinical Guidelines Outline Optimal Treatment of Helicobacter pylori InfectionFor pharmacists wondering whether bismuth quadruple therapy still reigns as the gold standard, the wait is over—the latest recommendations are here.
Latest:
Clinical Trials of Veterinary Medications Differ From Drugs for Human UseFDA regulations under Food, Drug, and Cosmetic Act outline efficacy, safety requirements for animal pharmaceuticals.
Latest:
Student Pharmacists Can Play Important Role as Patient AdvocatesEducation and support inspire trust between patients and pharmacists.
Latest:
The Future of the 340B Drug Pricing Program in Modern Health CareAn examination of the 340B Drug Pricing Program's original intent, current challenges, and potential resolutions in today's complex health care landscape.
Latest:
Challenges and Opportunities in the Treatment of Ewing SarcomaLittle progress has been made in developing treatments that can help to stop Ewing sarcomas from spreading or coming back.
Latest:
The Impact of Postherpetic Neuralgia on Frailty in Older Adults with Herpes ZosterResults support a 2020 meta-analysis showing that older adults with chronic pain are nearly twice as likely to develop frailty compared to those without chronic pain.
Latest:
Postpandemic Future Is Bright for TechniciansTapping techs as immunizers opens up greater visibility and new source of health care labor.
Latest:
Trilaciclib Protects Against Chemotherapy-Induced MyelosuppressionTreatment's approval marks exciting new development for patients with ES-SCLC to prevent CIM.
Latest:
Technology in the Classroom Helps Shape Tomorrow’s Pharmacy LeadersAutomation can enhance safety and efficiency and allow staff to concentrate on higher-value tasks as direct patient care roles expand.
Latest:
The Dilemma of Childhood Vaccines Post PandemicWith the end of the PREP Act Provisions in sight, pharmacists should Reflect on their impact and plan to continue them.
Latest:
Cost Avoidance and Satisfaction Associated With Clinical Pharmacy Services in a Veterans Affairs Specialty ClinicAn infusion and specialty clinical pharmacist is a valuable integrated member of the health care team as demonstrated by cost avoidance and high satisfaction reported by both veterans and specialty providers.
Latest:
Advancements in the Management of Nonmetastatic Castrate-Resistant Prostate Cancer: A Review of Second-Generation AntiandrogensTreatment selection includes patient factors, cost, adverse effects, and drug interactions.
Latest:
Adapting to the FDA's Phenylephrine Status Change in OTC Cold and Congestion MedicationsPharmacists' expertise is crucial in educating patients about regulatory changes, helping them navigate alternative formulations, and providing insights into evidence-based choices.
Latest:
Catalyzing Commitment: The Symphony of AI-Powered Medication AdherenceArtificial intelligence–driven reminders empower patients, combating forgetfulness and enhancing treatment adherence for better health outcomes.
Latest:
Overview of PARP Inhibitors in the Treatment of Ovarian CancerThere are 3 PARP inhibitors that are FDA approved in multiple settings of ovarian cancer.
Latest:
Case Report: Rivastigmine Overexposure Toxicities with Weight LossWith gastrointestinal-based adverse effectss for rivastigmine and other cholinesterase inhibitors, a weight of <50 and <55 kg respectively leads to an increased risk for toxicities.
Latest:
The Role of the Ambulatory Care Pharmacist in Promoting Vaccine ConfidenceA pharmacist’s role in the ambulatory care setting has traditionally included a review of medications for potential drug-drug interactions and adverse events, medication reconciliation, and the provision of counseling services.
Latest:
Overcharging Hospital Pharmacies: Unnecessary Hidden CostsIn hospital pharmacies, roughly 2% of pharmacy spend can be overcharge.
Latest:
Focusing Treatment on Multiple Pathways to Reduce Resistance and Improve Outcomes in Triple-Positive Breast CancerUsing new treatment advances, traditional medications, genetic profiles, immunotherapies, and individualized plans enables providers to improve outcomes for patients with TPBC.
Latest:
Zuranolone Offers An Innovative Treatment for Postpartum DepressionZuranolone enhances health care providers’ ability to address the complex needs of patients with PPD, offering new hope for rapid and sustained relief from depressive symptoms.
Latest:
I Think When I Am Older, I Might Be a Pharmacist! My Experience Writing a Children's Book About PharmacyChildren's books about the field of pharmacy are surprisingly scarce.
Latest:
Let’s Not Sugar Coat It: HbA1c is the Imperfect Diabetes DiagnosticWhen diabetes is uncontrolled, higher percentages of hemoglobin become glycated, which causes elevated HbA1c and glucose levels to rise within the body.
Latest:
Updated C. Difficile Infection Guidelines Incorporate New TrialsInfectious Disease Society of America and Society for Healthcare Epidemiology of America make 3 new treatment recommendations for adults.
Latest:
Pirtobrutinib and BTK Inhibitors in the CLL Treatment LandscapeThis review discusses the prevalence, mechanisms of development, and evolving treatment landscape in chronic lymphocytic leukemia.
Latest:
Naloxone Training Requirements Vary Among StatesNew access laws allow pharmacists to establish standing orders with specific physicians or follow blanket, statewide protocols.
